s2wR != mse, FDA != EMA [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2017-03-04 19:13 (1939 d 07:55 ago) – Posting: # 17133
Views: 16,555

I like that post, d_labes :-),

» But s2wR = MSE is not necessarily true in all cases, although it is in many cases a reasonable assumption.

...and accordingly when the optimizer fails, plugging in the GLM residual (expressed as MSE) as a new starter value for s2wR (and even S2wT where applicable) may be a very decent last-ditch attempt.

» Moreover the FDA evaluation uses intra-subject constrasts to evaluate s2wR

What does this mean? Don't you usually get it from the REML covarance matrix?

I think EMA's approach can be condensed into intra-Subject contrasts to derive S2wR from completers.

Pass or fail!

Complete thread:

UA Flag
 Admin contact
22,167 posts in 4,645 threads, 1,572 registered users;
online 10 (0 registered, 10 guests [including 10 identified bots]).
Forum time: Sunday 04:08 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz